Saqib Islam bought stock once, on Mar 3, 2020

Saqib Islam, J.D. is a biotechnology executive and corporate insider who served as chief executive officer and a member of the board of directors of SpringWorks Therapeutics, Inc. (NASDAQ: SWTX), a clinical-stage biopharmaceutical company focused on developing medicines for patients with severe rare diseases and cancer.( A founding member of SpringWorks’ executive team at its launch in 2017, he initially held the roles of chief financial officer and chief business officer before being appointed CEO in 2018 and joining the company’s board.( As CEO, he led key business operations and strategic corporate planning and has executed multiple insider share transactions in SpringWorks stock, including a June 3, 2024 sale of 49,000 shares disclosed in SEC filings.(

Before SpringWorks, Islam served as chief business officer at Moderna Therapeutics, where he oversaw global strategic planning, corporate development, and business development.( Earlier in his career, he was executive vice president, chief strategy and portfolio officer at Alexion Pharmaceuticals and held managing director roles in the healthcare investment banking divisions of Morgan Stanley and Credit Suisse, giving him more than 25 years of international business management and healthcare finance experience.( Islam has also served on the boards of Passage Bio and ARS Pharmaceuticals, Inc., contributing to the strategic direction of multiple life sciences companies.( He earned a bachelor’s degree from McGill University and a J.D. from Columbia Law School, where he was recognized as a Harlan Fiske Stone Scholar.(

Written by Perplexity from public sources.